HK Stock Market Move | JW THERAP-B (02126) opened nearly 15% higher; CAR-T drug Relma-cel included in the medical insurance catalog.

date
09:25 16/11/2026
avatar
GMT Eight
JW THERAP-B (02126) opened nearly 15% higher. As of press time, it is up 14.84% at HK$3.095, with a turnover of HK$1.0012 million.
JW THERAP-B (02126) opened nearly 15% higher, up 14.84% as of press time at HK$3.095, with turnover of HK$1.0012 million. On the news front, on November 14, the National Healthcare Security Administration officially released the 2026 "National Basic Medical Insurance, Maternity Insurance and Work-Related Injury Insurance Drug Catalog," which included JW Therapeutics' CAR-T drug Breyanzi (relma-cel injection), making it the first and currently only CAR-T drug to be included in the national basic medical insurance catalog. It is understood that CAR-T has long carried a "sky-high price" label. Before entering medical insurance, relma-cel was priced at RMB1.29 million per vial. According to public reports, after medical insurance negotiations, the price of relma-cel was reduced to within RMB300,000, and eligible patients, after medical insurance reimbursement, are expected to keep their out-of-pocket portion within RMB100,000.